The Octane Neuro Tech Forum 2026 is scheduled for March 26-27, 2026, at VEA Newport Beach, A Marriott Resort & Spa in Newport Beach, California. The event aims to assemble industry leaders, clinicians, investors, and entrepreneurs to drive innovation in the neurotechnology sector. As part of Octane's Innovation Event Series, the forum will feature keynote speaker Dr. Adnan Siddiqui, CEO and CMO of the Jacobs Institute, alongside more than 30 expert speakers.
Discussions will center on emerging neurotech technologies, digital health innovation, brain-computer interfaces, and the evolving investment landscape. The forum's agenda includes innovation panels, investor-focused sessions, company presentations, and networking opportunities designed to foster partnerships and accelerate the development of next-generation neurotechnology solutions. Octane fosters a future-focused ecosystem of tech and medtech companies across Southern California by connecting people, resources, and capital. Its mission is to drive innovation and growth by facilitating the exchange of ideas, knowledge, and resources that fuel the growth and development of Southern California's tech and medtech industries.
The Neuro Tech Forum represents a significant convergence point for stakeholders in a rapidly advancing field. For business and technology leaders, the event offers critical insights into investment opportunities and technological breakthroughs that could reshape healthcare, human-computer interaction, and treatment for neurological conditions. The focus on brain-computer interfaces highlights a frontier area with potential applications in medical rehabilitation, communication aids, and even consumer technology, signaling where venture capital and research efforts are increasingly directed.
By bringing together clinicians and entrepreneurs, the forum bridges the gap between clinical needs and technological solutions, potentially accelerating the translation of research into viable products. The investor-focused sessions will provide a window into the financial dynamics and risk assessments associated with neurotech ventures, information crucial for executives making strategic investment decisions. The networking component is designed to catalyze collaborations that could lead to new startups, partnerships, or funding rounds, directly impacting the pace of innovation in the industry.
For the broader industry, such gatherings help establish standards, share best practices, and identify regulatory hurdles, collectively advancing the field. The global neurotechnology market is projected for substantial growth, and forums like this one help solidify Southern California's position as a hub for this innovation. The implications extend beyond business, as advancements discussed could lead to breakthrough therapies for conditions like paralysis, epilepsy, or depression, ultimately affecting patient care worldwide. More information about Octane is available at https://www.octaneoc.org. The full press release can be viewed at https://ibn.fm/43FAw.
